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Abstract: I n t r o d u c t i o n: Contrast-induced nephropathy (CIN) is acute kidney injury (AKI), caused 
by administration of iodinated contrast media. The reported risk factors of CIN are: pre-existing renal 
dysfunction, admission anemia, diabetic nephropathy, old age, dehydration, high volume and osmolarity 
of administered contrast media. Patients with acute myocardial infarction (AMI) have threefold higher 
risk of developing CIN.
T h e  a i m of the study was to identify risk factors of CIN among patients who underwent percutaneous 
coronary intervention (PCI) due to AMI.
M e t h o d s: This retrospective single-centre study included 257 patients (mean age, 69.19 ± 1.4 years; 
men 66.15%) undergoing PCI for AMI between January 2012 and January 2013. Demographic data, type 
and location of MI, co-morbidities and laboratory results were analysed.
R e s u l t s: CIN was found in 50 out of 257 patients (19.5%). Patients who developed CIN were older 
(p = 0.001), more commonly had chronic kidney disease (p = 0.01) and lower LVEF (p = 0.01). Baseline 
Red Cell Distribution Width (RDW) was significantly higher in the CIN group (14.85 ± 4.6 vs. 13.62 ± 1.3, 
p = 0.001). CK-MB levels on admission were significantly higher in the CIN group compared to the non-
CIN group (95.6 ± 129.9 vs. 47.03 ± 61.3, p = 0.001). Multivariate model including “classical” CIN risk 
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factors revealed that only baseline CK-MB level (p = 0.001), age >75 years (p = 0.001) and baseline RDW 
(p = 0.03) were independent predictors for the development of CIN.
C o n c l u s i o n: In conclusion, increased CK-MB on admission as a surrogate of time of ischemia, and 
increased RDW levels on admission as a marker of chronic inflammation are independently associated 
with higher risk of CIN among patients treated with primary PCI.
Key words: coronary angiography, contrast agents, primary PCI, acute renal disease.
Background
Contrast-induced nephropathy (CIN) is acute kidney injury (AKI), caused by 
administration of iodinated contrast media, that may lead to kidney insufficiency 
and end-stage renal disease [1]. The incidence of CIN reported in the literature can 
range between 1 and 50%, largely depending on the definition of CIN used and 
co-morbidities of the study population. The reported risk factors of CIN are: pre-
existing renal dysfunction, diabetic nephropathy, old age, dehydration, high volume 
and osmolarity of administered contrast media. The most commonly used definition 
of CIN is an absolute increment of serum creatinine (SCr) exceeding 0.5   mg/dl 
or a  relative increase of 25% over the baseline level within 72 hours of contrast 
administration [2]. Jin et al. reported that development of CIN after percutaneous 
coronary intervention  (PCI) in the course of acute myocardial infarction (AMI) was 
associated with the increased mortality rate and end-stage renal disease (25.4% in 
CIN group vs. 6.3% in non-CIN group, p <0.001). In the CIN group 45.9% of patients 
developed chronic kidney disease and thus had higher incidence of death or dialysis. 
The risk was lower for patients in the CIN group who developed transient kidney 
insufficiency (defined as kidney function recovery after 1 month) and was the lowest 
in the non-CIN group (34.1%, 17.7% and 6.3%, respectively; p <0.001) [3]. Patients 
with chronic kidney disease (CKD) have the higher risk of the sudden cardiac death 
and this risk increases with the progression of renal dysfunction [4]. Since CKD is an 
important risk factor of CIN, it is crucial to avoid deterioration of kidney function in 
these patients. In the research of Santos et al. the risk factors of CIN in the univariate 
logistic regression analysis were: old age, LVEF  ≤40% and Killip classification ≥2, 
whereas in the multivariate analysis no independent predictors of CIN were found [5]. 
Ivanes et al. found that only the glomerular filtration rate and cardiogenic shock at 
admission were independent variables predicting CIN [6]. We aimed to assess which 
routinely available clinical parameters may be helpful in the identification of patients 
at risk of CIN after PCI in the course of MI.
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Materials and methods
Study population
Our retrospective single-centre study included all adult patients undergoing primary 
coronary intervention (PCI) for acute myocardial infarction (AMI). Both non-
ST-segment elevation myocardial infarction (NSTEMI) and ST-segment elevation 
myocardial infarction (STEMI) patients hospitalized between January 2012 and 
January 2013 in the Department of Interventional Cardiology John Paul II Hospital 
in Krakow were included. AMI was diagnosed according to the Third Universal 
Definition of Myocardial Infarction announced in 2012 by ESC [7].
Exclusion criteria were end stage renal failure requiring dialysis and exposure to 
contrast media within 7 days before the index procedure. 
Methods
The database included basic demographic data, type and location of MI, co-mor-
bidities and laboratory results listed in Table 1. Particular emphasis was placed on 
the co-morbidites that are reported to be risk factors of CIN such as pre-existing 
chronic kidney disease (eGFR <60 ml/min/1.73 m2), arterial hypertension, diabetes 
mellitus. In addition, we analyzed the presence of obesity defined as BMI ≥30 kg/m2, 
hyperlipidemia, peripheral arterial disease, tobacco smoking and severe left ventricle 
systolic dysfunction (LVEF <30%). Factors related to procedure included culprit 
artery, contrast type and amount, as well as contrast volume per kilogram. 
All baseline blood samples were obtained immediately after patient’s admission to 
the Emergency Department, including: sCr, complete blood count (CBC) and cardiac 
necrosis markers: high-sensitivity troponin T (hsTnT), creatine kinase (CK) and 
creatine kinase-MB (CK-MB). Creatinine measurements were repeated at 24, 48 and 
72 hours after index procedure. Estimation of the glomerular filtration rate was based 
on the modification of diet in renal disease (MDRD) equation. All the collected blood 
samples were processed in the central hospital laboratory. 
Statistical analysis
Quantitative parameters were expressed as the mean value ± standard deviation.
Qualitative parameters were coded using Arabic numerals. The data were analyzed 
using STATISTICA 10.0 software suite (StatSoft). The Shapiro-Wilk test and the 
Kolmogorov-Smirnov test with the Lilliefors correction were used to verify the 
normality of distribution of results. Depending on the result of the normality of 
distribution, the data were analyzed using parametric or non-parametric tests. For 
all variables, both qualitative and quantitative, a  univariate regression analysis was 
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performed. The null hypothesis (H0) was rejected at the established level alpha lower 
than 0.05.
Results
Baseline characteristics
During 13 months of the study duration 455 patients were admitted to the department 
due to AMI. Of this group, 257 patients with complete data on renal function at 
baseline and during the 3-day follow-up period were included in the study. 198 
patients were excluded due to insufficient data, mainly lack of second or third 
creatinine measurement in most of cases due to early discharge before day 3 after 
uncomplicated procedure. Mean age was 69.19 ± 1.4 years and 170 (66.15%) were 
males. CIN, defined as an absolute increment of more than 0.5 mg/dl or a  relative 
increase by more than 25% over the baseline SCr level within 72 hours of contrast 
administration, was found in 50 out of 257 patients (19.5%). The study population 
was divided into “CIN Group” and “non-CIN Group”. Overall, the mortality rate in 
our population was 2.3% and was significantly higher in the CIN Group (4 (8%) 
vs. 2  (1%); p = 0.003). Baseline clinical and procedural characteristics and laboratory 
examination results are shown in Table 1.
Table 1. Clinical characteristics of study population and subgroups with or without CIN.
Total population 
(n = 257)
CIN (+)
(n = 50)
CIN (–)
(n = 207) P value
Age years (± SD) 69.15 (± 11.4) 74.7 (± 11.6) 67.8 (± 11.0) 0.001
Age >75  years (%) 88 (34%) 30 (60%) 58 (28%) 0.01
Women n (%) 87 (34%) 23 (46%) 64 (31%) 0.43
Mortality rate n (%) 6 (2.3%) 4 (8%) 2 (1%) 0.003
BMI kg/m2 27.4 (± 5.52) 27.16 (± 4.49) 27.5 (± 5.72) 0.38
LVEF % (± SD) 43.54 (± 13.2) 38.75 (± 14.9) 44.43 (± 12.8) 0.01
LVEF <30  n (%) 29 (11%) 12 (24%) 17 (8.2%) 0.001
Risk factors
Diabetes n (%) 96 (37%) 26 (52%) 70 (34%) 0.38
Arterial hypertension n (%) 222 (86%) 42 (84%) 180 (87%) 0.8
Dyslipidemia n (%) 197 (77%) 37 (74%) 160 (77%) 0.78
Current smoker n (%) 32 (12%) 2 (4%) 30 (14%) 0.47
Peripheral artery disease  n (%) 24 (9%) 7 (14%) 17 (8%) 0.18
Chronic kidney disease n (%) 93 (36%) 25 (50%) 68 (33%) 0.01
 Creatine kinase-MB and red cell distribution width as predictors of contrast-induced nephropathy… 91
Total population 
(n = 257)
CIN (+)
(n = 50)
CIN (–)
(n = 207) P value
Diagnosis
STEMI n (%) 118 (46%) 30 (60%) 88 (43%)
NSTEMI n (%) 139 (54%) 18 (36%) 121 (58%)
Laboratory data
Hct n (%) 40.7 (± 5.2) 39.7 (± 6.1) 41.03 (± 4.9) 0.1
RDW n (%) 13.87 (± 2.59) 14.85 (± 4.6) 13.62 (± 1.3) 0.001
hsTnT ng/ml (± SD) 0.64 (± 3.08) 1.24 (± 2.9) 0.5 (± 1.2) 0.001
CK-MB U/l (± SD) 56.48 (± 81.4) 95.6 (± 129.9) 47.03 (± 61.3) 0.001
CK-MB >55 n (%) 82 (25.3%) 20 (40%) 47 (22.7%) 0.01
CPK U/l (± SD) 475.49 (± 764.42) 745.1 (± 1157.92) 410.05 (± 620.26) 0.02
SCr mmol/l (± SD) 100.9 (± 48.8) 120.9 (± 87.6) 96.1 (± 31.8) 0.43
eGFR  ml/min/1.73 m2 (± SD) 65.14 (± 18.9) 58.13 (± 24.0) 66.85 (± 17.1) 0.26
PCI data
Contrast volume ml (± SD) 244.15 (± 91.5) 233.3 (± 88.9) 246.75 (± 92.16) 0.22
Contrast vol. >100 ml n (%) 233 (90%) 46 (92%) 187 (90%) 0.54
Contrast vol. >200 ml n (%) 103 (40%) 17 (34%) 86 (42%) 0.33
Contrast vol. >300 ml n (%) 77 (30%) 11 (22%) 66 (32%) 0.15
Contrast vol./kg ml/kg  (± SD) 3.41 (± 6.37) 3.01 (± 1.27) 3.68 (± 7.84) 0.95
Culprit artery
Left main coronary artery n (%) 4 (2%) 0 4 (2%)
ANOVA
 0.083
LAD artery n (%) 87 (34%) 23 (46%) 64 (31%)
Circumflex artery  n (%) 67 (26%) 14 (28%) 53 (26%)
Right coronary artery  n (%) 83 (32%) 10 (20%) 73 (35%)
BMI — body mass index, CK-MB — creatine kinase-MB, CPK — creatine phosphokinase, eGFR — estinated 
glomerular filtration rate, Hct — hematocrit, hsTnT — high sensitivity troponin T, LAD — left anterior 
descending, LVEF — left ventricle ejection fraction, NSTEMI — non-ST-segment elevation myocardial infarction, 
PCI — percutaneous coronary intervention, RDW — red cell distribution width, SCr — serum creatinine, 
STEMI — ST-segment elevation myocardial infarction.
Patients who developed CIN were older (p = 0.001), had higher prevalence of 
chronic kidney disease (p = 0.01) and lower LVEF (p = 0.01) (Fig. 1). The incidence 
of diabetes mellitus and hypertension was not significantly different between the two 
groups. No significant differences in gender or BMI were identified between the groups. 
Baseline hematocrit levels were significantly lower in patients who developed CIN. 
Table 1. Cont.
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Baseline eGFR and serum creatinine levels were not significantly different between 
the groups. Baseline Red Cell Distribution Width (RDW) was substantially higher 
in the CIN group (14.8 ± 4.6 vs. 13.6 ± 1.3, p = 0.001). CK-MB levels at admission 
were significantly higher in the CIN group compared to the non-CIN group as well 
(95.6 ± 129.9 vs. 47.03 ± 61.3, p = 0.001) (Fig. 2). Baseline hsTnT and CK levels were 
also higher in the CIN group (1.2 ± 2.9 vs. 0.5 ± 1.2; p = 0.001 and 745.1 ± 1157.92 
vs. 410.05 ± 620.26; p = 0.02, respectively). The most prevalent culprit vessel was the 
left anterior descending artery in the CIN group and right coronary artery in the 
non-CIN group, but the difference was not statistically significant. Average amount 
of injected contrast was 244.15 ± 91.5 ml. More than 200 ml of contrast was used in 
103 patients and more than 300 ml was administered to 77 patients. Injected contrast 
type and volume did not differ significantly between the groups. Moreover, amount of 
administrated contrast per kilogram was not significantly different between the groups.
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Fig. 1. Significantly different characteristics between the CIN and non-CIN groups. EF — ejection 
fraction, CKD — chronic kidney disease.
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Fig. 2. CK-MB levels in the CIN and non-CIN groups. CK-MB — creatine kinase-MB.
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Predictive factors of CIN
To assess independent predictors of CIN as a  dependent variable, stepwise logistic 
regression was performed. Initially, we analyzed all the univariate associations and 
demonstrated in the univariate model a  significant positive association between 
development of CIN and baseline CK-MB level, age above 75 years, smoking history, 
CKD, LVEF and STEMI presentation (Table 2). Baseline hsTnT and CPK level, as 
well as baseline sCr level and eGFR) also reached statistical significance. In order 
to include only one of the associated variables in our multivariate analysis, we 
investigated CK-MB and CKD further. Multivariate model revealed that only baseline 
CK-MB level (p = 0.002), age >75 years (p = 0.002) and baseline RDW (p = 0.02) were 
independent predictors of CIN development after urgent PCI in patients with AMI 
(Table 3) (Fig. 3). There was no significance in the Hosmer-Lemeshow test indicating 
that the model was properly matched (χ² = 3.36, p = 0.91).
Table 2. Predictive factors of CIN in AMI — univariate analysis. 
P value OR [95% CI]
Age (years) 0.001 1.06 [1.03–1.09]
Age >75 years 0.001 1.96 [1.42–2.71]
Female gender 0.046 1.38 [1.01–1.89]
Obesity 0.540 1.11 [0.79–1.57]
LVEF 0.009 0.97 [0.95–0.99]
Risk factors
Diabetes 0.089 1.32 [0.96–1.81]
Arterial hypertension 0.810 0.95 [0.65–1.49]
Dyslipidemia 0.790 0.95 [0.66–1.37]
Current smoker 0.027 0.25 [0.06–1.09]
Peripheral artery disease 0.210 1.36 [0.85–2.19]
Chronic kidney disease 0.015 1.49 [1.08–2.04]
Diagnosis
STEMI 0.026 1.42 [1.04–1.95]
Laboratory data
RBC 0.580 1.00 [1.0–1.0]
Hct 0.137 0.96 [0.9–1.01]
hsTnT 0.018 1.20 [1.02–1.41]
CK-MB 0.001 1.01 [1.00–1.01]
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P value OR [95% CI]
CK-MB >55 U/l 0.020 2.23 [1.16–4.28]
RDW 0.002 1.28 [1.07–1.54]
CPK 0.012 1.00 [1.00–1.00]
SCr 0.004 1.01 [1.00–1.02]
eGFR 0.004 0.98 [0.96–0.99]
PCI data
Contrast volume 0.360 0.998 [0.995–1.002]
Contrast volume >100 ml 0.530 1.60 [0.35–7.34]
Contrast volume >200 ml 0.330 0.85 [0.61–1.18]
Contrast volume/kilogram 0.690 0.96 [0.8–1.16]
CK-MB — creatine kinase-MB, CPK — ctreatine phosphokinase, eGFR — estinated glomerular filtration rate, Hct 
— hematocrit, hsTnT — high sensitivity troponin T, LVEF — left ventricle ejection fraction, PCI — percutaneous 
coronary intervention, RDW — red cell distribution width, SCr — serum creatinine, STEMI — ST-segment 
elevation myocardial infarction.
Table 3. Predictive factors of CIN in AMI — multivariate analysis. 
P value OR [CI]
Age >75 0.002 3.11 [1.50–6.40]
Female gender 0.94 1.03 [0.46–2.32]
Obesity 0.64 1.22 [0.53–2.80]
LVEF 0.06 0.97 [0.95–1.00]
Diabetes 0.38 1.44 [0.64–3.26]
Arterial hypertension 0.64 0.76 [0.23–2.45]
Dyslipidemia 0.28 1.74 [0.63–4.75]
Current smoker 0.57 0.61 [0.11–3.28]
Chronic kidney disease 0.5 1.34 [0.58–3.08]
HCT 0.96 1.00 [0.93–1.07]
CK-MB 0.002 1.01 [1.00–1.01]
RDW 0.02 1.30 [1.04–1.61]
Contrast volume >200 ml 0.36 0.69 [0.31–1.53]
CK-MB — creatine kinase-MB, Hct — hematocrit, LVEF — left ventricle ejection fraction, RDW — red cell 
distribution width.
Table 2. Cont.
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 Fig. 3. Odds ratios (OR) and 95% confidence intervals (CI) of CIN risk factors in the multivariate logistic 
regression analysis. Vol. — volume, RDW — red cell distribution width, CK-MB — creatine kinase-MB, 
Hct — hematocrit, CKD — chronic kidney disease, EF — ejection fraction, DM — diabetes mellitus, 
AH — arterial hypertension.
Discussion
In our study we investigated predictors of contrast induced nephropathy among 
patients in acute settings of myocardial infarction. This group may be at a particular 
risk of CIN because many risk factors may be present in this population such 
as low hydration, decreased cardiac output causing renal hypoperfusion, drugs 
that compromise renal function and could not be discontinued prior to the 
procedure e.g.  metformin. The main finding of our study was that risk factors for 
the development of CIN in the case of myocardial infarction (with exception to 
age), differ from classical predictors of AKI among patients undergoing elective 
procedures. Our data indicate that CK-MB as a surrogate for the objectively measured 
time of ischemia and elevated levels of RDW as a  marker of inflammation and high 
oxidative stress were found to be independent predictors of CIN in patients treated 
with primary PCI. Prolonged hemodynamic deterioration as well as significant 
arrhythmias and  conductance disturbances resulting from MI may lead to reduced 
renal blood flow due to vasoconstriction and impaired vasodilatation of cortical- and 
outer medullary vasculature, release of reactive oxygen species and direct tubular 
toxicity [1]. This hypoxic change depending on the duration of ischemia and its degree 
of severity may lead to reversible loss of renal function without structural damage but 
also in severe cases to irreversible loss or delayed restoration of renal function [8, 9].
Our findings were in line with previous reports suggesting a  connection between 
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the longer time to reperfusion and the presence of CIN in patients undergoing 
primary PCI [10, 11].
High RDW as measurement of anisocytosis, which is related to impaired 
erythropoiesis and erythrocyte degradation and may reflect chronic inflammatory 
process and high level of oxidative stress [12, 13]. The higher level of RDW, interpreted 
as a marker of chronic inflammation in a group of 4159 patients, was a known risk 
factor for MI, increased in-hospital and long-term mortality among patients suffering 
from MI stroke, and symptomatic HF in patients with CAD [14]. Elevated RDW is also 
associated with increased levels of proinflammatory cytokines such as hsCRP, tumor 
necrosis factor TNF and interleukin 6 [15, 16]. In our group increased RDW levels on 
admission were associated with the development of CIN during the first three days 
of hospitalization. Similarly to our findings Kurtul et al. found that increased RDW 
levels at baseline were significantly associated with increased risk of CIN in patients 
who underwent urgent PCI due to ACS [17]. These observations were consistent with 
the report of Mizuno concerning the predictive value of RDW levels for the CIN 
development among 102 patients with STEMI treated with primary PCI  [18]. Since 
RDW is a standard laboratory test available in every CBC result, it may also be easily 
used in CIN risk assessment in ACS patients treated with PCI.
As expected, old age was associated with the occurrence of CIN, both in univariate 
and multivariate regression analyses. It is known that the advanced age is associated 
with a decline in GFR and older patients tend to have more comorbidities. Increased 
risk of CIN probably results from the combination of a more severe coronary disease 
with a  longer interventional procedure, an increased rate of heart failure associated 
with administration of intravenous diuretics and presence of a  congestion being 
a  contraindication to intravenous hydration. Higher proportion of diabetes and 
arterial hypertension in the elderly, leading to microvascular renal lesions, may also 
contribute to the higher risk of CIN [2].
The incidence of CIN in our study was 19.5%, which is a similar result to the studies 
that evaluated the occurrence of CIN among patients with ST-elevation MI. However 
such prevalence is substantially higher compared to the general population of patients 
undergoing radiological examinations with contrast media administration [19]. 
Our study group was admitted to the hospital in the acute setting, so the 
patients usually could not be properly hydrated and at that period no protocol of 
routine intravenous hydration was used. Such a  procedure, recommended by the 
CIN Consensus Working Panel was introduced later [20]. The risk factors of CIN 
were common in our study group and they partially overlapped with risk factors of 
coronary artery disease. Although only 6 patients died in our population, CIN was 
strongly associated with the higher mortality rate. This confirms that the development 
of CIN is an important negative prognostic factor in patients after PCI due to AMI 
similar as in previous studies [21, 22].
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Early identification of the subgroup of patients with particularly high risk of 
CIN could allow to plan strict follow-up of kidney function and receive best possible 
care. The study revealed that several variables reported to date as CIN risk factors 
were associated with CIN in the univariate analysis. They included: old age, female 
gender, low ejection fraction, cigarettes smoking, chronic kidney disease as well as its 
biochemical markers (creatinine level and eGFR), STEMI, RDW, biochemical tests for 
myonecrosis such as hsTnT, CK-MB and CPK. However, in the multivariate analysis 
only the advanced age, RDW and time of ischemia measured as CK-MB were found to 
be independent predictors of CIN in AMI patients treated with urgent primary PCI.
Although of borderline significance, CK-MB was another independent predictor 
of CIN. The underlying reason may be the fact that baseline CK-MB correlates 
with the time of myocardial ischemia in ACS. Long time of ongoing ischemia 
may affect cardiac output, causing hypoperfusion of numerous organs including 
kidneys. Concomitant administration of contrast media may increase the risk of 
CIN. According to our best knowledge, no studies have investigated the relationship 
between baseline CK-MB and CIN in patients with ACS. As CK-MB is a  laboratory 
test performed in almost every patient with ACS it might be useful in CIN risk 
assessment in this clinical setting.
Several classical risk factors were not predictive of CIN in our population. 
Surprisingly, the volume of contrast medium was not significantly correlated with 
the occurrence of CIN. Advanced skills of the operators allowed to use minimal 
necessary contrast volumes. In most patients the volume injected was lower than 
200 ml and did not exceed 400 ml of contrast in any of patient in this group. Modern 
contrast agent used in our patients may also explain this difference in comparison 
with older studies. Our population benefited from the use of low-osmolarity agents, 
which are considered to be less nephrotoxic. In our cohort, diabetes did not emerge as 
a predictor of CIN. Although it did not reach statistical significance, diabetes tended 
to be more prevalent among the patients with CIN. 
Limitations
The study is retrospective but complete data was obtained in majority of cases. It was 
not possible for the patients whose clinical course was uncomplicated and therefore 
had creatinine level test ordered only once after procedure. It was because ordering 
laboratory tests repeatedly in patients with uneventful clinical course may have been 
regarded as excessive and unnecessary. Nevertheless, in these patients there was only 
a  slight chance of CIN, since they had uneventful clinical course and few if any risk 
factors. However, they had to be excluded from the study and it is therefore possible 
that such a  selection bias caused relatively high incidence of CIN in the presented 
analysis.
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Conclusion
In conclusion our findings suggest that in the context of AMI, unlike the case of 
elective procedures, independent predictors of CIN are CK-MB levels on admission 
as an objective surrogate of ischemic time and RDW levels as a  marker of increased 
oxidative stress and inflammation associated with myocardial necrosis.
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